NASDAQ:STTK

Shattuck Labs Stock Insider Trading

Healthcare > Biotechnology

Buy STTK

*Your capital is at risk

$4.75

-0.120 (-2.46%)

At Close: Jun 03, 2026

Shattuck Labs Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.24. In total, the insiders bought 169.94M and sold 65.03K STTK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.24
● Buy	169.94M shares
● Sell	65.03K shares
89% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence May 12, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.24. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 10, 2026 Sell	Common Stock F-InKind	Pandite Arundathy N. Chief Medical Officer	Officer	6 851 Value: $32.5K
Jan 10, 2026 Buy	Common Stock A-Award	Pandite Arundathy N. Chief Medical Officer	Officer	487 800 Value: $2.32M
Jan 10, 2026 Buy	Common Stock A-Award	Shukla Abhinav A. Chief Technical Officer	Officer	315 500 Value: $1.50M
Jan 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Stout Stephen See Remarks	Officer	351 400 Value: $1.67M
Jan 10, 2026 Sell	Common Stock F-InKind	Stout Stephen See Remarks	Officer	4 153 Value: $19.7K
Jan 10, 2026 Buy	Common Stock A-Award	Deyoung Casi Chief Business Officer	Officer	381 600 Value: $1.81M
Jan 10, 2026 Sell	Common Stock F-InKind	Deyoung Casi Chief Business Officer	Officer	5 699 Value: $27.1K
Jan 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Neill Andrew R Chief Financial Officer	C-Suite Officer	549 800 Value: $2.61M
Jan 10, 2026 Sell	Common Stock F-InKind	Neill Andrew R Chief Financial Officer	C-Suite Officer	6 660 Value: $31.6K
Jan 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Schreiber Taylor Chief Executive Officer	CEO / President	1 548 300 Value: $7.35M
Aug 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Ashiya Mona Director	Director	66 300 Value: $65.6K
Aug 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Baker Daniel G. Director	Director	66 300 Value: $65.6K
Aug 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Baker Daniel G. Director	Director	66 300 Value: $65.6K
Aug 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Ashiya Mona Director	Director	66 300 Value: $65.6K
Aug 25, 2025 Buy	Common Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	15 366 490 Value: $16.7M
Aug 25, 2025 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	10 111 384 Value: $1K
Aug 25, 2025 Buy	Common Stock P-Purchase	Orbimed Advisors Llc Director	Director	5 255 106 Value: $4.56M
Aug 25, 2025 Buy	Common Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	3 073 298 Value: $3.33M
Aug 25, 2025 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	2 022 277 Value: $202
Aug 25, 2025 Buy	Common Stock P-Purchase	Orbimed Advisors Llc Director	Director	1 051 021 Value: $912.0K
Aug 25, 2025 Buy	Common Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	15 366 490 Value: $16.7M
Aug 25, 2025 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	10 111 384 Value: $1K
Aug 25, 2025 Buy	Common Stock P-Purchase	Ashiya Mona Director	Director	5 255 106 Value: $4.56M
Aug 25, 2025 Buy	Common Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	3 073 298 Value: $3.33M
Aug 25, 2025 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	2 022 277 Value: $202

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SHATTUCK LABS, INC.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorpor...

Read Full Profile Here